| Gene | Associated with LEOPARD SYNDROME in | Link to HGNC | Cytogenetic band | Number of associated diseases | Associated diseases |
|---|---|---|---|---|---|
| PTPN11 | ClinVar, OMIM, HUMSAVAR | HGNC link | 12q24.13 | 4 | PS163950, 607785, 156250, PS151100 |
| RAF1 | ClinVar, OMIM, HUMSAVAR | HGNC link | 3p25.2 | 3 | PS163950, PS115200, PS151100 |
| BRAF | ClinVar, OMIM, HUMSAVAR | HGNC link | 7q34 | 8 | 605027, PS115150, PS151100, PS155600, 211980, PS188550, PS163950, 114500 |
Download the disease annotation in CSV format
| Gene1 | Gene2 | Direct Interaction | Number of shared interactors | Shared genes in interaction |
|---|---|---|---|---|
| PTPN11 | RAF1 | No | 7 | PDGFRB, MAP2K1, JAK1, JAK2, MAP3K5, EGFR, FYN |
| PTPN11 | BRAF | No | 1 | MAP2K1 |
| RAF1 | BRAF | Yes | 26 | MAP2K2, CDC37, YWHAE, MAPK1, BRAF, NEDD4L, KSR1, RAP1A, HSPA5, YWHAB, YWHAH, PRKCE, BRAP, RAF1, YWHAZ, HRAS, HSP90AA1, AKT1, BAD, HSPA8, MRAS, MAPK3, YWHAG, SFN, YWHAQ, MAP2K1 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
| Gene1 | Gene2 | Direct Interaction | Interaction mode | Number of shared interactors | Shared genes in interaction |
|---|---|---|---|---|---|
| PTPN11 | RAF1 | No | - | 50 | PIK3R3, FCER1A, RAP1A, MS4A2, PRKCZ, MAPK3, TP53, MAPK1, JAK2, SRC, KRAS, PIK3CG, PRKACA, RAP1B, FCER1G, RPS27A, STAT2, PDGFRB, CXCL12, MAP2K2, PIK3CA, UBA52, MAPK7, INPP5D, LCK, HRAS, NOS3, VAV1, PIK3CB, DOK1, PPP2CA, AKT1, RHOA, PPP2R1A, FYN, MYC, STAT3, IL2, UBB, IL3, IGF1R, HSPA4, GNB2L1, SPRY2, JAK1, IGF1, UBC, PIK3CD, PIK3R5, MAP2K1 |
| PTPN11 | BRAF | No | - | 15 | MAP2K2, AKT1, CRK, MAPK1, HRAS, MAPK3, PPP2CA, SPRY2, UBC, KRAS, RAP1A, PPP2R1A, PRKACA, RAP1B, MAP2K1 |
| RAF1 | BRAF | Yes | binding | 40 | MAP2K2, HSP90AB1, CDC37, KSR2, YWHAE, MAPK1, PPP2CA, PAK2, KSR1, RAP1A, PRKACA, RAP1B, YWHAB, PRKCE, PRKCD, YWHAH, RRAS, CNKSR3, PRKCG, RHEB, YWHAZ, PRKCA, HRAS, HSP90AA1, PPP2R2B, AKT1, PAK4, PPP2R1A, KRAS, PRKCB, MRAS, MAPK3, SPRY2, YWHAG, SFN, UBC, PRKCQ, PIN1, YWHAQ, MAP2K1 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
| Gene1 | Gene2 | Direct Interaction | Complexes | Number of shared interactors | Shared genes in interaction |
|---|---|---|---|---|---|
| RAF1 | BRAF | Yes | RAF1-BRAF complex, RAS stimulated;BRAF-RAF1-14-3-3 complex;MAP2K1-BRAF-RAF1-YWHAE-KSR1 complex | 11 | MAP2K2, YWHAH, YWHAE, KSR1, YWHAG, YWHAB, SFN, CNKSR1, YWHAQ, MAP2K1, YWHAZ |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
| KEGG term | KEGG term ID | IC | Number of genes with the same term | Genes |
|---|---|---|---|---|
| Neurotrophin signaling pathway | hsa04722 | 5.78 | 3 | PTPN11, BRAF, RAF1 |
| Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 | 3 | PTPN11, BRAF, RAF1 |
| Renal cell carcinoma | hsa05211 | 6.6 | 3 | PTPN11, BRAF, RAF1 |
| Proteoglycans in cancer | hsa05205 | 5.02 | 3 | PTPN11, BRAF, RAF1 |
| Chronic myeloid leukemia | hsa05220 | 6.48 | 3 | PTPN11, BRAF, RAF1 |
| Melanoma | hsa05218 | 6.56 | 2 | BRAF, RAF1 |
| Bladder cancer | hsa05219 | 7.38 | 2 | BRAF, RAF1 |
| Focal adhesion | hsa04510 | 4.92 | 2 | BRAF, RAF1 |
| Pancreatic cancer | hsa05212 | 6.56 | 2 | BRAF, RAF1 |
| Endometrial cancer | hsa05213 | 6.81 | 2 | BRAF, RAF1 |
| Colorectal cancer | hsa05210 | 6.52 | 2 | BRAF, RAF1 |
| Glioma | hsa05214 | 6.66 | 2 | BRAF, RAF1 |
| Prostate cancer | hsa05215 | 6.11 | 2 | BRAF, RAF1 |
| Long-term potentiation | hsa04720 | 6.64 | 2 | BRAF, RAF1 |
| FoxO signaling pathway | hsa04068 | 5.63 | 2 | BRAF, RAF1 |
| Serotonergic synapse | hsa04726 | 5.84 | 2 | BRAF, RAF1 |
| Chemokine signaling pathway | hsa04062 | 5.19 | 2 | BRAF, RAF1 |
| Progesterone-mediated oocyte maturation | hsa04914 | 6.18 | 2 | BRAF, RAF1 |
| Hepatitis C | hsa05160 | 5.68 | 2 | BRAF, RAF1 |
| Vascular smooth muscle contraction | hsa04270 | 5.74 | 2 | BRAF, RAF1 |
| Pathways in cancer | hsa05200 | 3.98 | 2 | BRAF, RAF1 |
| Rap1 signaling pathway | hsa04015 | 4.97 | 2 | BRAF, RAF1 |
| Ras signaling pathway | hsa04014 | 4.9 | 2 | PTPN11, RAF1 |
| Non-small cell lung cancer | hsa05223 | 6.88 | 2 | BRAF, RAF1 |
| ErbB signaling pathway | hsa04012 | 6.15 | 2 | BRAF, RAF1 |
| Acute myeloid leukemia | hsa05221 | 6.74 | 2 | BRAF, RAF1 |
| MAPK signaling pathway | hsa04010 | 4.63 | 2 | BRAF, RAF1 |
| Long-term depression | hsa04730 | 6.74 | 2 | BRAF, RAF1 |
| Regulation of actin cytoskeleton | hsa04810 | 4.9 | 2 | BRAF, RAF1 |
| Insulin signaling pathway | hsa04910 | 5.55 | 2 | BRAF, RAF1 |
| cAMP signaling pathway | hsa04024 | 5.05 | 2 | BRAF, RAF1 |
| Alcoholism | hsa05034 | 5.59 | 2 | BRAF, RAF1 |
| REACTOME term | REACTOME term ID | IC | Number of genes with the same term | Genes |
|---|---|---|---|---|
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by Interleukins | R-HSA-449147 | 4.71 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by Leptin | R-HSA-2586552 | 5.1 | 3 | PTPN11, BRAF, RAF1 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 | 3 | PTPN11, BRAF, RAF1 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.85 | 3 | PTPN11, BRAF, RAF1 |
| Downstream signal transduction | R-HSA-186763 | 4.65 | 3 | PTPN11, BRAF, RAF1 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.73 | 3 | PTPN11, BRAF, RAF1 |
| Developmental Biology | R-HSA-1266738 | 3.48 | 3 | PTPN11, BRAF, RAF1 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.85 | 3 | PTPN11, BRAF, RAF1 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 | 3 | PTPN11, BRAF, RAF1 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.89 | 3 | PTPN11, BRAF, RAF1 |
| Signalling by NGF | R-HSA-166520 | 4.23 | 3 | PTPN11, BRAF, RAF1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 | 3 | PTPN11, BRAF, RAF1 |
| IRS-mediated signalling | R-HSA-112399 | 4.87 | 3 | PTPN11, BRAF, RAF1 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 | 3 | PTPN11, BRAF, RAF1 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 | 3 | PTPN11, BRAF, RAF1 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 | 3 | PTPN11, BRAF, RAF1 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by FGFR | R-HSA-190236 | 4.67 | 3 | PTPN11, BRAF, RAF1 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 | 3 | PTPN11, BRAF, RAF1 |
| Immune System | R-HSA-168256 | 2.37 | 3 | PTPN11, BRAF, RAF1 |
| Innate Immune System | R-HSA-168249 | 3.17 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by PDGF | R-HSA-186797 | 4.53 | 3 | PTPN11, BRAF, RAF1 |
| DAP12 signaling | R-HSA-2424491 | 4.64 | 3 | PTPN11, BRAF, RAF1 |
| Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 | 3 | PTPN11, BRAF, RAF1 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by EGFR | R-HSA-177929 | 4.59 | 3 | PTPN11, BRAF, RAF1 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 | 3 | PTPN11, BRAF, RAF1 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 | 3 | PTPN11, BRAF, RAF1 |
| DAP12 interactions | R-HSA-2172127 | 4.56 | 3 | PTPN11, BRAF, RAF1 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 | 3 | PTPN11, BRAF, RAF1 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 | 3 | PTPN11, BRAF, RAF1 |
| Axon guidance | R-HSA-422475 | 3.93 | 3 | PTPN11, BRAF, RAF1 |
| Signal Transduction | R-HSA-162582 | 1.78 | 3 | PTPN11, BRAF, RAF1 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 | 2 | BRAF, RAF1 |
| Interleukin-2 signaling | R-HSA-451927 | 5.05 | 2 | BRAF, RAF1 |
| Frs2-mediated activation | R-HSA-170968 | 5.12 | 2 | BRAF, RAF1 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.66 | 2 | BRAF, RAF1 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.85 | 2 | BRAF, RAF1 |
| CREB phosphorylation through the activation of Ras | R-HSA-442742 | 8.23 | 2 | BRAF, RAF1 |
| RAF activation | R-HSA-5673000 | 8.34 | 2 | BRAF, RAF1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.15 | 2 | BRAF, RAF1 |
| Signaling by VEGF | R-HSA-194138 | 4.66 | 2 | BRAF, RAF1 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.12 | 2 | BRAF, RAF1 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 | 2 | PTPN11, RAF1 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.32 | 2 | BRAF, RAF1 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.98 | 2 | PTPN11, BRAF |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.89 | 2 | PTPN11, BRAF |
| Adaptive Immune System | R-HSA-1280218 | 3.19 | 2 | PTPN11, RAF1 |
| Neuronal System | R-HSA-112316 | 4.82 | 2 | BRAF, RAF1 |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | R-HSA-112314 | 5.85 | 2 | BRAF, RAF1 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.28 | 2 | BRAF, RAF1 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 | 2 | BRAF, RAF1 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.18 | 2 | PTPN11, BRAF |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.15 | 2 | BRAF, RAF1 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.09 | 2 | BRAF, RAF1 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 10.4 | 2 | BRAF, RAF1 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 | 2 | BRAF, RAF1 |
| Signalling to RAS | R-HSA-167044 | 5.08 | 2 | BRAF, RAF1 |
| Activation of NMDA receptor upon glutamate binding and postsynaptic events | R-HSA-442755 | 7.7 | 2 | BRAF, RAF1 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.15 | 2 | BRAF, RAF1 |
| Prolonged ERK activation events | R-HSA-169893 | 5.11 | 2 | BRAF, RAF1 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.66 | 2 | BRAF, RAF1 |
| Signalling to ERKs | R-HSA-187687 | 5.04 | 2 | BRAF, RAF1 |
| Signaling by GPCR | R-HSA-372790 | 2.68 | 2 | BRAF, RAF1 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.15 | 2 | BRAF, RAF1 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.15 | 2 | BRAF, RAF1 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.03 | 2 | PTPN11, BRAF |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.12 | 2 | PTPN11, BRAF |
| ARMS-mediated activation | R-HSA-170984 | 5.12 | 2 | BRAF, RAF1 |
| SOS-mediated signalling | R-HSA-112412 | 5.15 | 2 | BRAF, RAF1 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.15 | 2 | BRAF, RAF1 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 | 2 | BRAF, RAF1 |
| Hemostasis | R-HSA-109582 | 3.98 | 2 | PTPN11, RAF1 |
| Term | New enriched term | IC | P value | Genes |
|---|---|---|---|---|
| Ras guanyl-nucleotide exchange factor activity (GO:0005088) | NEW | 4.31 | 0.001 | PTPN11, BRAF, RAF1 |
| mitogen-activated protein kinase kinase binding (GO:0031434) | - | 6.97 | 0.001 | BRAF, RAF1 |
| receptor signaling protein activity (GO:0005057) | - | 4.76 | 0.009 | PTPN11, BRAF, RAF1 |
| guanyl-nucleotide exchange factor activity (GO:0005085) | NEW | 4.02 | 0.004 | PTPN11, BRAF, RAF1 |
| enzyme binding (GO:0019899) | - | 2.27 | 0.03 | PTPN11, BRAF, RAF1 |
| receptor signaling protein serine/threonine kinase activity (GO:0004702) | - | 5.23 | 0.002 | BRAF, RAF1 |
| MAP kinase kinase kinase activity (GO:0004709) | - | 6.6 | 0.002 | BRAF, RAF1 |
| GO | IC | Number of genes with the same GO | Genes |
|---|---|---|---|
| cytoplasm (GO:0005737) | 1.01 | 3 | PTPN11, BRAF, RAF1 |
| cytosol (GO:0005829) | 1.68 | 3 | PTPN11, BRAF, RAF1 |
| intracellular membrane-bounded organelle (GO:0043231) | 0.6 | 3 | PTPN11, BRAF, RAF1 |
| nucleus (GO:0005634) | 1.07 | 3 | PTPN11, BRAF, RAF1 |
| cell part (GO:0044464) | 0.11 | 3 | PTPN11, BRAF, RAF1 |
| cytoplasmic part (GO:0044444) | 0.82 | 3 | PTPN11, BRAF, RAF1 |
| mitochondrion (GO:0005739) | 2.42 | 3 | PTPN11, BRAF, RAF1 |
| intracellular organelle (GO:0043229) | 0.51 | 3 | PTPN11, BRAF, RAF1 |
| intracellular part (GO:0044424) | 0.28 | 3 | PTPN11, BRAF, RAF1 |
| membrane-bounded organelle (GO:0043227) | 0.47 | 3 | PTPN11, BRAF, RAF1 |
| organelle (GO:0043226) | 0.4 | 3 | PTPN11, BRAF, RAF1 |
| cell projection (GO:0042995) | 2.47 | 2 | BRAF, RAF1 |
| membrane (GO:0016020) | 0.68 | 2 | BRAF, RAF1 |
| plasma membrane (GO:0005886) | 1.39 | 2 | BRAF, RAF1 |
| Term | New enriched term | IC | P value | Genes |
|---|---|---|---|---|
| protein kinase complex (GO:1902911) | NEW | 5.31 | 0.025 | BRAF, RAF1 |
| anchoring junction (GO:0070161) | NEW | 3.61 | 0.026 | PTPN11, BRAF, RAF1 |
| adherens junction (GO:0005912) | NEW | 3.66 | 0.023 | PTPN11, BRAF, RAF1 |
| transferase complex (GO:1990234) | NEW | 3.32 | 0.037 | PTPN11, BRAF, RAF1 |
| cell-substrate adherens junction (GO:0005924) | NEW | 3.83 | 0.014 | PTPN11, BRAF, RAF1 |
| focal adhesion (GO:0005925) | NEW | 3.83 | 0.013 | PTPN11, BRAF, RAF1 |
| cell-substrate junction (GO:0030055) | NEW | 3.82 | 0.015 | PTPN11, BRAF, RAF1 |